TELOTelo Genomics Corp.

TSXV · CA · Healthcare · Diagnostics & Research · telodx.com

0.0500CAD+11.11%Mkt Cap: 3.66M $P/E: —4d ago

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily …

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap3.66M $

Enterprise Value3.90M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-1.98M $

Revenue/Share—

Last Price0.0500 CAD

Fiscal Year EndJun 2025

MR QuarterMar 2026

Employees—

CountryCA

SectorHealthcare

IndustryDiagnostics & Research

ISINCA87975M2085

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-2.86

EV/Revenue—

P/S—

P/B-5.00

EPS (TTM)-0.03

EPS (Forward)—

52W Range

0.035025% of range0.0950

52W High0.0950 CAD

52W Low0.0350 CAD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-527.93%

ROA-298.34%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.70M $

CapEx (TTM)2.37K $

FCF Margin—

FCF Yield-8.08%

Net Debt247.31K $

Net Debt/EBITDA-0.18

Balance Sheet

Debt/Equity—

Current Ratio0.09

Quick Ratio0.07

Book Value/Sh-0.0100 CAD

Cash/Share0.0100 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateNov 22, 2019

Splits

Last Split1:5

Split DateNov 22, 2019

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.100.43M

Float74.45M

Insiders2.98%

Institutions0.40%

Short Interest

Short Ratio0.2d

Short % Out.0.00%

Shares Short2.99K

Short (prev mo.)14.30K

Technical

SMA 500.0465 (+7.5%)

SMA 2000.0511 (-2.2%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)27.91K

Avg Vol (10d)10.67K

Technical Indicators

RSI (14)58.0

MACD-0.0006

MACD Signal-0.0015

MACD Hist.+0.0008

BB Upper0.0499 CAD

BB Middle0.0447 CAD

BB Lower0.0396 CAD

BB Width22.81%

ATR (14)0.0029 CAD

Vol Ratio (20d)22.67x